Literature DB >> 96134

Attachment role of gonococcal pili. Optimum conditions and quantitation of adherence of isolated pili to human cells in vitro.

W A Pearce, T M Buchanan.   

Abstract

Gonoccocal pili facilitate attachment of virulent Neisseria gonorrhoeae to human cells. To characterize this attachment function, purified gonococcal pili isolated from four strains possessing antigenically distinct pili were radiolabeled with 125I and used to measure the attachment of pili to various human cells in vitro. Human buccal and cervical-vaginal mucosal epithealial cells, fallopian tube mucosa, and sperm bound pili in greater numbers per micrometer2 of surface area (1--10) than fetal tonsil fibroblasts, HeLa M cells, erythrocytes, or polymorphonuclear leukocytes. This cell specificity of attachment suggests a greater density of membrane pili binding sites on cells similar or identical to cells from natural sites of infection. The pili binding sites were quantitated as 1 X 10(4) per cervical-vaginal squamous cell. Pili of all antigenic types attached equally to a given cell type, implying that the attachment moiety of each pilus was similar. Attachement of gonoccocal pili to human cells occurred quickly with saturation of presumed receptor sites within 20--60 min. Attachment was temperature dependent (37 degrees greater than 20 degrees greater than 4 degrees C), and pH dependent (3.5 less than 4.5 less than 5.5 less than 7.5). Attachment was inhibited by antibody to pili (homologous pili Ab greater than heterologous Ab). The extent of possible protection against gonococcal infection due to inhibition of pili-mediated attachment might prove limited as a result of the considerable antigenic heterogeneity among pili and the observation that blockage of pili attachment is maximal only with antibody to pili of the infecting strain.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 96134      PMCID: PMC372611          DOI: 10.1172/JCI109018

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes.

Authors:  A J SBARRA; M L KARNOVSKY
Journal:  J Biol Chem       Date:  1959-06       Impact factor: 5.157

2.  Restriction of the mobility of lymphocyte immunoglobulin receptors by concanavalin A.

Authors:  I Yahara; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

3.  Rocket immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

4.  Pili as a mediator of the attachment of gonococci to human erythrocytes.

Authors:  T M Buchanan; W A Pearce
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

5.  Role of the K88 antigen in the pathogenesis of neonatal diarrhea caused by Escherichia coli in piglets.

Authors:  G W Jones; J M Rutter
Journal:  Infect Immun       Date:  1972-12       Impact factor: 3.441

6.  A new colonial type of N. gonorrhoeae.

Authors:  K Chan; G M Wiseman
Journal:  Br J Vener Dis       Date:  1975-08

7.  Virus-receptor interaction in an adenovirus system.

Authors:  L Philipson; K Lonberg-Holm; U Pettersson
Journal:  J Virol       Date:  1968-10       Impact factor: 5.103

8.  NEISSERIA GONORRHOEAE. I. VIRULENCE GENETICALLY LINKED TO CLONAL VARIATION.

Authors:  D S KELLOGG; W L PEACOCK; W E DEACON; L BROWN; D I PIRKLE
Journal:  J Bacteriol       Date:  1963-06       Impact factor: 3.490

9.  The fluid mosaic model of the structure of cell membranes.

Authors:  S J Singer; G L Nicolson
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

10.  Studies on gonococcus infection. I. Pili and zones of adhesion: their relation to gonococcal growth patterns.

Authors:  J Swanson; S J Kraus; E C Gotschlich
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  35 in total

1.  The cytotoxic fimbrial structural subunit of Xenorhabdus nematophila is a pore-forming toxin.

Authors:  Jyotirmoy Banerjee; Jitendra Singh; Mohan Chandra Joshi; Shubhendu Ghosh; Nirupama Banerjee
Journal:  J Bacteriol       Date:  2006-09-01       Impact factor: 3.490

2.  Structural and antigenic analysis of meningococcal piliation.

Authors:  R W Olafson; P J McCarthy; A R Bhatti; J S Dooley; J E Heckels; T J Trust
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

Review 3.  Structure and function of pili of pathogenic Neisseria species.

Authors:  J E Heckels
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

4.  Gonococcal pili. Primary structure and receptor binding domain.

Authors:  G K Schoolnik; R Fernandez; J Y Tai; J Rothbard; E C Gotschlich
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

5.  Antigen-specific serotyping of Neisseria gonorrhoeae: characterization based upon principal outer membrane protein.

Authors:  T M Buchanan; J F Hildebrandt
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

6.  Gonococcal pilus vaccine. Studies of antigenicity and inhibition of attachment.

Authors:  E C Tramont; J C Sadoff; J W Boslego; J Ciak; D McChesney; C C Brinton; S Wood; E Takafuji
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

7.  Attachment of bacteria to mammalian surfaces.

Authors:  B Sugarman
Journal:  Infection       Date:  1980       Impact factor: 3.553

8.  New Method for isolation of immunologically pure pili from Escherichia coli.

Authors:  T K Korhonen; E L Nurmiaho; H Ranta; C S Edén
Journal:  Infect Immun       Date:  1980-02       Impact factor: 3.441

9.  Attachment of gonococcal pili to lectin-resistant clones of Chinese hamster ovary cells.

Authors:  E R Gubish; K C Chen; T M Buchanan
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

10.  Genital antibody response to a parenteral gonococcal pilus vaccine.

Authors:  D McChesney; E C Tramont; J W Boslego; J Ciak; J Sadoff; C C Brinton
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.